May 2026
1. MWAPASA V, Asante KP, Milligan P, Akech S, et al
   Impact of introducing RTS,S/AS01(E) malaria vaccine on mortality in young children in Ghana, Kenya, and Malawi: an observational evaluation of a cluster-randomised implementation programme.
   Lancet. 2026;407:1796-1808.
   

   >> Share

   
   April 2026
2. STEINHARDT LC, Kwambai TK, Oneko M, Ouma E, et al
   Safety and efficacy of the monoclonal antibody L9LS for malaria prevention in children exposed to perennial malaria transmission in Kenya: a randomised, double-blind, placebo-controlled, phase 2 trial.
   Lancet. 2026;407:1614-1625.
   

   >> Share

   
   
3. ENGWERDA CR, Haque A
   Antibody-based malaria prevention in an intense perennial transmission setting.
   Lancet. 2026;407:1575-1577.
   

   >> Share

   
   November 2025
4. PRASAD A
   Fitsum Tadesse: shaping malaria research in sub-Saharan Africa.
   Lancet. 2025;406:2049.
   

   >> Share

   
   July 2025
5. HALLETT TB, Menzies NA, Resch S, Pretorius C, et al
   The case for optimal investment in combating HIV, tuberculosis, and malaria: a global modelling study.
   Lancet. 2025 Jul 3:S0140-6736(25)00831-1. doi: 10.1016/S0140-6736(25)00831.
   

   >> Share

   
   June 2025
6. SYMONS TL, Lubinda J, McPhail M, Saddler A, et al
   Estimating the potential malaria morbidity and mortality avertable by the US President's Malaria Initiative in 2025: a geospatial modelling analysis.
   Lancet. 2025;405:2231-2240.
   

   >> Share

   
   
7. BOUM Y, Erondu NA
   Reinforcing resilience: confronting the consequences of global malaria aid cuts in Africa.
   Lancet. 2025;405:2184-2186.
   

   >> Share

   
   May 2025
8. ATERE AO, Mustapha FB, Mustapha MJ
   Logistics of the malaria vaccine roll-out in Nigeria.
   Lancet. 2025;405:1815.
   

   >> Share

   
   March 2025
9. LACERDA MVG, Bassat Q
   Mapping the malaria burden in the context of a global pandemic: progress, hiccups, and challenges.
   Lancet. 2025 Mar 5:S0140-6736(25)00418-0. doi: 10.1016/S0140-6736(25)00418.
   

   >> Share

   
   
10. WEISS DJ, Dzianach PA, Saddler A, Lubinda J, et al
    Mapping the global prevalence, incidence, and mortality of Plasmodium falciparum and Plasmodium vivax malaria, 2000-22: a spatial and temporal modelling study.
    Lancet. 2025 Mar 5:S0140-6736(25)00038-8. doi: 10.1016/S0140-6736(25)00038.
    

    >> Share

    
    February 2025
11. KIRBY T
    Marcus Lacerda: aiming to eliminate vivax malaria.
    Lancet. 2025;405:456.
    

    >> Share

    
    January 2025
12. DATOO MS, Hill AVS, Beaumont E, Bradley J, et al
    The R21/Matrix-M malaria vaccine: questions remain - Author's reply.
    Lancet. 2025;405:299-301.
    

    >> Share

    
    
13. AABY P, Bjorkman A, Schapira A, Benn CS, et al
    The R21/Matrix-M malaria vaccine: questions remain.
    Lancet. 2025;405:299.
    

    >> Share

    
    
14. OBARO S, Mokuolu O, Michelow IC
    The R21/Matrix-M malaria vaccine: questions remain.
    Lancet. 2025;405:299.
    

    >> Share

    
    
15. LI Y, Liu G
    The R21/Matrix-M malaria vaccine: questions remain.
    Lancet. 2025;405:298-299.
    

    >> Share

    
    
16. GONCALVES MADA, Morais H, Ribeiro Junior HL
    Malaria and undernutrition in Angola.
    Lancet. 2025;405:296-297.
    

    >> Share

    
    
17. IMPOUMA B, Adidja A, Mboussou F, Cabore J, et al
    Malaria vaccine introduction in Africa: progress and challenges.
    Lancet. 2025 Jan 21:S0140-6736(24)02841-1. doi: 10.1016/S0140-6736(24)02841.
    

    >> Share

    
    December 2024
18. OCHOMO EO, Gimnig JE, Awori Q, Abong'o B, et al
    Effect of a spatial repellent on malaria incidence in an area of western Kenya characterised by high malaria transmission, insecticide resistance, and universal coverage of insecticide treated nets (part of the AEGIS Consortium): a cluster-randomised,
    Lancet. 2024 Dec 19:S0140-6736(24)02253-0. doi: 10.1016/S0140-6736(24)02253.
    

    >> Share

    
    
19. SWAI JK, Moore SJ
    Beyond repellents: spatial emanators for the control of malaria in Africa.
    Lancet. 2024 Dec 19:S0140-6736(24)02754-5. doi: 10.1016/S0140-6736(24)02754.
    

    >> Share

    
    April 2024
20. ASANTE KP, Mathanga DP, Milligan P, Akech S, et al
    Feasibility, safety, and impact of the RTS,S/AS01(E) malaria vaccine when implemented through national immunisation programmes: evaluation of cluster-randomised introduction of the vaccine in Ghana, Kenya, and Malawi.
    Lancet. 2024 Apr 4:S0140-6736(24)00004-7. doi: 10.1016/S0140-6736(24)00004.
    

    >> Share

    
    
21. DAUBENBERGER CA, Silva JC
    First-generation malaria vaccine successfully implemented in three African countries.
    Lancet. 2024 Apr 4:S0140-6736(23)02892-1. doi: 10.1016/S0140-6736(23)02892.
    

    >> Share

    
    February 2024
22. THE LANCET
    Malaria vaccines: a test for global health.
    Lancet. 2024;403:503.
    

    >> Share

    
    
23. ADEPOJU P
    Routine malaria vaccinations begin.
    Lancet. 2024;403:423.
    

    >> Share

    
    
24. MOORTHY V, Hamel MJ, Smith PG
    Malaria vaccines for children: and now there are two.
    Lancet. 2024 Feb 1:S0140-6736(23)02743-5. doi: 10.1016/S0140-6736(23)02743.
    

    >> Share

    
    
25. DATOO MS, Dicko A, Tinto H, Ouedraogo JB, et al
    Safety and efficacy of malaria vaccine candidate R21/Matrix-M in African children: a multicentre, double-blind, randomised, phase 3 trial.
    Lancet. 2024 Feb 1:S0140-6736(23)02511-4. doi: 10.1016/S0140-6736(23)02511.
    

    >> Share

    
    January 2024
26. NAKWEYA G
    Cabo Verde eliminates malaria.
    Lancet. 2024;403:341.
    

    >> Share

    
    
27. KAMYA MR, Kakuru A, Dorsey G
    Dihydroartemisinin-piperaquine for prevention of malaria in pregnant women living with HIV.
    Lancet. 2024 Jan 12:S0140-6736(24)00048-5. doi: 10.1016/S0140-6736(24)00048.
    

    >> Share

    
    
28. BARSOSIO HC, Madanitsa M, Ondieki ED, Dodd J, et al
    Chemoprevention for malaria with monthly intermittent preventive treatment with dihydroartemisinin-piperaquine in pregnant women living with HIV on daily co-trimoxazole in Kenya and Malawi: a randomised, double-blind, placebo-controlled trial.
    Lancet. 2024 Jan 12:S0140-6736(23)02631-4. doi: 10.1016/S0140-6736(23)02631.
    

    >> Share

    
    November 2023
29. ASSEFA A, Parr JB
    Universal radical cure: prospects and challenges for malaria elimination.
    Lancet. 2023 Nov 15:S0140-6736(23)01950-5. doi: 10.1016/S0140-6736(23)01950.
    

    >> Share

    
    
30. THRIEMER K, Degaga TS, Christian M, Alam MS, et al
    Primaquine radical cure in patients with Plasmodium falciparum malaria in areas co-endemic for P falciparum and Plasmodium vivax (PRIMA): a multicentre, open-label, superiority randomised controlled trial.
    Lancet. 2023 Nov 15:S0140-6736(23)01553-2. doi: 10.1016/S0140-6736(23)01553.
    

    >> Share

    
    
31. POESPOPRODJO JR, Douglas NM, Ansong D, Kho S, et al
    Malaria.
    Lancet. 2023 Nov 1:S0140-6736(23)01249-7. doi: 10.1016/S0140-6736(23)01249.
    

    >> Share

    
    October 2023
32. ADEPOJU P
    Malaria community welcomes WHO vaccine approval.
    Lancet. 2023;402:1316.
    

    >> Share

    
    September 2023
33. KESSY SA, Tibenderana JR
    Zanzibar's malaria elimination efforts: progress, challenges, and lessons.
    Lancet. 2023;402:774.
    

    >> Share

    
    
34. HAWLEY WA, Laihad FJ, Ochomo E, Achee NL, et al
    What constitutes high-quality evidence for malaria vector control?
    Lancet. 2023;402:773-774.
    

    >> Share

    
    July 2023
35. SAMARASEKERA U
    Climate change and malaria: predictions becoming reality.
    Lancet. 2023;402:361-362.
    

    >> Share

    
    
36. DEVI S
    12 countries to get first doses of malaria vaccine.
    Lancet. 2023;402:172.
    

    >> Share

    
    May 2023
37. ZAROCOSTAS J
    Gavi unveils malaria vaccine plans.
    Lancet. 2023;401:1485.
    

    >> Share

    
    April 2023
38. KEATING C
    Artesunate versus quinine: the controlled trials watershed.
    Lancet. 2023;401:1329-1331.
    

    >> Share

    
    
39. PASRICHA SR, Mwangi MN, Moya E, Ataide R, et al
    Ferric carboxymaltose versus standard-of-care oral iron to treat second-trimester anaemia in Malawian pregnant women: a randomised controlled trial.
    Lancet. 2023 Apr 20:S0140-6736(23)00278-7. doi: 10.1016/S0140-6736(23)00278.
    

    >> Share

    
    March 2023
40. KAKURU A, Jagannathan P
    Can we reduce malaria in pregnancy and improve birth outcomes?
    Lancet. 2023 Mar 10:S0140-6736(23)00101-0. doi: 10.1016/S0140-6736(23)00101.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share